Atara Biotherapeutics, Inc. (ATRA)
15.64
+0.56
(+3.71%)
USD |
NASDAQ |
Dec 09, 16:00
15.64
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Total Liabilities (Quarterly): 66.80M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| Pacira Biosciences, Inc. | 570.36M |
| ADMA Biologics, Inc. | 137.50M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.17M |
| Shareholders Equity (Quarterly) | -36.63M |
| Debt to Equity Ratio | -1.600 |
| Current Ratio | 1.021 |
| Net Debt Paydown Yield | 6.05% |